‘Weight-loss drugs’ may benefit patients with diabetes, obesity, heart, liver conditions
Major trials link semaglutide to fewer heart attacks and slower kidney decline.…
Notification
Show More
Major trials link semaglutide to fewer heart attacks and slower kidney decline.…
You are free to republish this article online or in print, provided that you attribute the author and Willow Health Media, and link back to the original article.
Note: Images are not included unless otherwise specified.
Copy and paste the HTML below into your site:
Remember to include the attribution and a backlink to Willow Health Media.
Loading article details…